Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV A Bladder Cancer”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Testing effectiveness (Phase 2)Study completedNCT01191892
What this trial is testing

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more
Cardiff University 82
Testing effectiveness (Phase 2)Study completedNCT01821105
What this trial is testing

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV A Bladder Cancer+3 more
Ohio State University Comprehensive Cancer Center 21
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Study completedNCT00066352
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00101608
What this trial is testing

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Transitional Cell CarcinomaBladder NeoplasmsKidney Neoplasms+3 more
Bristol-Myers Squibb 150
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT01222676
What this trial is testing

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Who this might be right for
Bladder Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 45
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)WithdrawnNCT05496192
What this trial is testing

Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

Who this might be right for
MelanomaUrothelial Carcinoma
Bristol-Myers Squibb
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Very early researchActive Not RecruitingNCT02812420
What this trial is testing

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

Who this might be right for
HydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT00030615
What this trial is testing

Decitabine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Bladder CancerRecurrent Breast Cancer+6 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT00006118
What this trial is testing

Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT02567409
What this trial is testing

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+1 more
National Cancer Institute (NCI) 87
Testing effectiveness (Phase 2)Study completedNCT00661609
What this trial is testing

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT00006376
What this trial is testing

R115777 in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
H. Lee Moffitt Cancer Center and Research Institute
Load More Results